TP53 and glioblastoma: The chemoresistance phenotype to TMZ, the standard treatment for glioblastoma, has been linked to a p53-specific mutation in glioblastoma cells through the increased expression of O6-methylguanine DNA-methyltransferase (MGMT), an enzyme that repairs DNA damage caused by TMZ (Wang et al., 2013).